Jul 01, 2020
Forest Devices Launches Collaboration with Alberta Health Services
Jul 01, 2020
Ascend Files First FDA 510(k) Submission Based on Acteev™ Technology
Jun 30, 2020
Versilon™ XFR: The First Hose With FDA Food Contact Compliance From Inner Layer to Outer Cover
Jun 25, 2020
PURE-MSK Empowers Businesses to Safely Reopen Amongst Continued Concerns of COVID-19 Spread
Jun 16, 2020
Cascade Chemistry Selected to Produce Active Pharmaceutical Ingredient for Clinical Trial Supplies of COVID-19 Investigational Drug RBT-9
Jun 15, 2020
PharmaCyte Biotech Successfully Accelerates Development of Container Closure Integrity Test for Pancreatic Cancer Clinical Trial Product
Jun 15, 2020
Biolinq Announces Results from First-in-Man Clinical Studies Showing Feasibility of a Novel, Minimally Invasive Approach to Continuous Glucose Monitoring in the Dermis
Jun 09, 2020
DOD to Fund a Multi-Center Randomized Clinical Trial of COVID-19 Treatment With ExThera’s Seraph 100 Blood Filter
Jun 04, 2020
PSC Software™ Has Developed a New Functionality in Our Industry Leading Real Time Inspection Management Software, ACE Inspection™, to Facilitate Remote Inspections and Audits
Jun 02, 2020
Association of American Physicians & Surgeons (AAPS) Sues the FDA to End Its Arbitrary Restrictions on Hydroxychloroquine
Jun 01, 2020
Longhorn Vaccines & Diagnostics and Cenetron Diagnostics Team up with Coca-Cola Bottlers to Produce COVID-19 Test Kits
May 27, 2020
Amivas (US), LLC Announces FDA Approval of Artesunate for Injection for Treatment of Severe Malaria
May 21, 2020
First Light Diagnostics Posters and Abstracts Accepted, Part of ECCMID 2020 Abstract Book
May 20, 2020
Global Impact Innovation Delivers on Mass-Scale Production of FDA Approved Hand Sanitizer to Address COVID-19 Shortage
May 15, 2020
Can-Fite Announces Pre-IND Submission to U.S. FDA for Piclidenoson in the Treatment of COVID-19 Infected Patients with Moderate-to-Severe Symptoms
May 13, 2020
Arbor Pharmaceuticals Announces FDA Filing Acceptance of New Drug Application (NDA) for AR19, an Investigational ADHD Prescription Stimulant Treatment Specifically Designed to Resist Physical Manipulation for Nonmedical Misuse or Abuse
May 12, 2020
Phillips-Medisize Announces the Appointment of Paul Chaffin as Senior Vice President and President, Medical and Pharmaceutical Solutions, Molex
May 12, 2020
FDA Expedites Clearance of Caption Health Ultrasound Software to Aid Frontline Healthcare Workers in Fight Against COVID-19 Pandemic
Apr 30, 2020
Applied DNA Accepted Into U.S. FDA’s Emerging Technology Program, Creating Pathway for Molecular Tagging of Pharmaceuticals and Packaging
Apr 30, 2020
Husco-Led Consortium Develops Breakthrough Face Mask for Frontline Healthcare Professionals